FinalDose is developing a programmable drug platform that uses DNA sequence recognition to identify and destroy cancer cells while leaving healthy cells untouched, starting with a modality aimed at all cancers. Founded in 2025 and based in San Francisco, the…
Infera builds an AI-native compiler and operating system for laboratories that converts natural language descriptions of experiments into validated protocols, material orders, instrument execution, and data analysis. Founded in 2026 and headquartered in San Francisco, the company is backed by…
AI agents are getting dramatically better at reasoning, planning, and taking actions in digital environments. However, when those same agents need to understand or act in the physical world — terrain, buildings, water features, land cover, or risk factors at…
AI coding agents are dramatically accelerating how fast software is written, reviewed, and shipped into production. Traditional application security tools and processes — built for slower, human-paced development — are increasingly unable to keep up. Attackers are already exploiting vulnerabilities…
In the legal industry, origination remains one of the most manual, relationship-dependent, and unevenly distributed functions. Top “rainmakers” often have dedicated support or innate networks; most partners do not. Osmaura is building the AI-native system designed to close that gap…